JELENA VESELINOVIC: Open Payments
NPI 1073625661 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 28 payments from 8 companies in 2025. Trend: 2023 $577 · 2024 $375 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $202 |
| Janssen Pharmaceuticals, Inc | 5 | $135 |
| Teva Pharmaceuticals USA, Inc. | 4 | $111 |
| Lundbeck LLC | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $67 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA, AUSTEDO XR, CAPLYTA, REXULTI, ERZOFRI EXTENDED-RELEASE, INGREZZA.
Industry payments across NY — which companies pay providers there.
